Results 131 to 140 of about 337 (145)

Dosing Recommendation Based on the Effects of Different Meal Types on Pexidartinib Pharmacokinetics in Healthy Subjects: Implementation of Model-informed Drug Development Strategy

Clinical Pharmacology in Drug Development, 2023
Hamim Zahir, Andrew J Wagner, Ophelia Yin   +2 more
exaly  

METHODS FOR ADMINISTERING PEXIDARTINIB

2022
SHUSTER DALE EDWARD, ZAHIR HAMIM, YIN OPHELIA QIPING, DROGARIS LEONIDAS DANIEL, DEV VIKRAM JEET, DELEVE LAURIE, LEWIS JAMES HENDRICKS   +6 more
openaire   +1 more source

PROCESS FOR PREPARING PEXIDARTINIB

2022
SCHRANCK JOHANNES, SLACK ERIC
openaire   +1 more source

Pexidartinib: Antrag auf Zulassung validiert

InFo Hämatologie + Onkologie, 2019
openaire   +1 more source

FDA approves pexidartinib for tenosynovial giant cell tumor

Case Medical Research, 2019
openaire   +1 more source

A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors

Investigational New Drugs, 2019
Chia-Chi Lin, James Chih-Hsin Yang, Ann-Lii Cheng   +2 more
exaly  

Pexidartinib-related AEs reported to FAERS

Reactions Weekly
openaire   +1 more source

Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers

Case Medical Research, 2019
openaire   +1 more source

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Case Medical Research, 2020
openaire   +1 more source

Real-World Patient Experience of Pexidartinib for Tenosynovial Giant-Cell Tumor.

Oncologist
William D Tap, Dong Dai, Feng Lin
exaly